Wall Street Analysts Believe Corcept (CORT) Could Rally 70.58%: Here's is How to Trade

Corcept Therapeutics (CORT) closed the last trading session at $34.94, gaining 5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $59.60 indicates a 70.6% upside potential. The average comprises five short-term price targets ranging from a low of $38 to a high of $78, with a standard deviation of $17.33. While the lowest estimate indicates an increase of 8.8% from the current price ...